欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号PT/H/2384/001
药品名称Imipenem/Cilastatin 500mg/500mg powder for solution for infusion
活性成分
    • cilastatin 500.0 mg
    • imipenem 500.0 mg
剂型Powder for solution for infusion
上市许可持有人HIKMA FARMACEUTICA (PORTUGAL) SA ESTRADA DO RIO MO, NO 8, 8A, E 8B FERVENCA, TERRUGEM SINTRA PT-2705-906 PORTUGAL
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • Spain (ES)
    • France (FR)
    • United Kingdom (Northern Ireland) (XI)
      PL 15413/0021 - 0018
    • Germany (DE)
      Imipenem/cilastatin Hikma 500 mg/500 mg Pulver zur Herstellung einer Infusionslösung
    • Ireland (IE)
    • Austria (AT)
      Imipenem/Cilastatin Hikma 500 mg/500 mg Pulver zur Herstellung einer Infusionslösung
    • Italy (IT)
    • Netherlands (NL)
许可日期2010/09/09
最近更新日期2023/12/28
药物ATC编码
    • J01DH51 imipenem and cilastatin
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase